Taeniasis clinical trials
The registry lists 13 studies for Taeniasis across 5 countries. 2 are recruiting or about to start. 3 of them are mainly about Taeniasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29. Counting its 2 narrower conditions too, such as Neurocysticercosis: 31 studies, 5 open.
Get an email when these change. Save the Taeniasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (4) · National Institute of Mental Health (NIMH) (2) · University of Oslo (1) · Oregon Health and Science University (1) · Institute of Tropical Medicine, Belgium (1) · Johns Hopkins Bloomberg School of Public Health (1) · Nicolaus Copernicus University (1) · Universidad Peruana Cayetano Heredia (1)
What is being tested here
Drugs under test in Taeniasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Praziquantel | 0 | 1 | 2 |
| Oxfendazole | 0 | 0 | 2 |
| Niclosamide | 0 | 0 | 2 |
| Pbr-28 | 0 | 0 | 1 |
Who these studies take
Of the 1 Taeniasis studies recruiting now, 0 (0%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (100%) | 1 (100%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 13 studies, recruiting or not: 46% stop at 75 or younger and 31% at 65; 62% take children; 0% are for women only and 0% for men only; 69% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 13 of 13. search them.
- Natural History of Treated Neurocysticercosis and Long-Term OutcomesRecruitingNCT000012051 country
- Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based StudyNot yet recruitingNCT04706819
- Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?CompletedNCT02612896Not applicable1 country
- Digital Health Promotion in Iringa, TanzaniaCompletedNCT03808597Not applicable1 country
- Phase I Trial Evaluating the Safety and Pharmacokinetics of OxfendazoleCompletedNCT02234570Phase 11 country
- Intestinal Parasites in Inhabitants of Kuyavian-Pomeranian Province in PolandCompletedNCT034904351 country
- PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28CompletedNCT00526916Phase 11 country
- PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FBCompletedNCT00527579Phase 11 country
- People Presenting With Neurocysticercosis in North AmericaTerminatedNCT022338551 country
- Single Ascending Dose Safety Study of OxfendazoleWithdrawnNCT01584362Phase 1
- Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)CompletedNCT00441285Phase 2/31 country
- Targeted Screening for Taenia Solium TapewormsCompletedNCT01296958Not applicable1 country
- Mass Treatment T Solium Community StudyTerminatedNCT00138359Not applicable1 country